U.S. Food and Drug Administration

Family showing off bandages from receiving a vaccination

Featured

COVID-19 Bivalent Vaccine Boosters

Now Authorized for Younger Age Groups

Coronavirus Disease 2019 (COVID-19)

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

FDA Monkeypox (mpox) Response

The FDA’s multipronged response to monkeypox (mpox) includes efforts in the areas of diagnostics, vaccines and therapeutics.

Drug Shortages

FDA works closely with manufacturers to prevent or reduce the impact of drug shortages.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Jan 27

FDA Proposes Individual Risk Assessment for Blood Donations, While Continuing to Safeguard U.S. Blood Supply

Jan 26

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

More Press Announcements

Newsroom Meetings Testimony Speeches

Jan 27

Sovos Brands Intermediate, Inc. Issues Allergy Alert on Undeclared Egg in Rao’s Slow Simmered Soup, Labeled as Chicken & Gnocchi but Containing Vegetable Minestrone

Food & Beverages

Jan 26

Joy Joy’s Bakery Issues Allergy Alert on Undeclared Wheat in Ube Spanish Bread, Ube Ensaymada, and Ube Roll

Food & Beverages

Jan 25

Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Image that depicts and asortment of pills on the left, and a headline that reads "New Drug Therapy Approvals 2022."

FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers

In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.

Illustration of leader speaking to Colleagues with cover of Leadership Modernization Action Plan (LMAP) report on left side.

Office of Digital Transformation’s New Focus on Technology Leadership

LMAP lays out our plans to strengthen our technology leadership capabilities to drive change at the business, technology, data, and cybersecurity levels.

Employee typing while staring at a computer screen.

FDA’s Cybersecurity Modernization Action Plan

CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.

Jan 30

CVM GFI #272 Practices to Prevent Unsafe Contamination of Animal Feed from Drug Carryover

Animal & Veterinary

Jan 27

Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

Biologics

Jan 27

CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern

Animal & Veterinary

FDA Guidance Search